Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medical Clinic Ginza is a specialized medical institution based in Tokyo, Japan, that focuses on advanced cancer immunotherapy and regenerative medicine. The clinic is a pioneer in the clinical application of autologous immune cell therapies, including Natural Killer (NK) cell therapy and dendritic cell vaccine therapy. By leveraging proprietary cell cultivation technologies, the facility provides personalized treatment plans designed to strengthen the patient's own immune response against various forms of cancer. In addition to oncology, the clinic offers regenerative treatments using mesenchymal stem cells for anti-aging and autoimmune conditions. Medical Clinic Ginza operates in close collaboration with the Biotherapy Institute of Japan to ensure high standards in cell processing and therapeutic efficacy. The institution serves as a key destination for patients seeking innovative, minimally invasive biological therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical Clinic Ginza.